Elijah M. Bolotin, PhD Founder, President and CEO
Dr. Bolotin has nearly 20 years in drug delivery, drug development and management. Prior to PharmaIN, Dr. Bolotin was Group Leader, Drug Delivery, and Technical Leader for New Technology Evaluation at Endorex Corp. (IL), and a research scientist at the NYU Medical Center (NY) and the All Union Cardio Center (Moscow). Dr. Bolotin received his PhD from The Hebrew University, Israel in biochemistry and pharmaceuticals.
Gerry Castillo, PhD Director of Research and Intellectual Property
Dr. Castillo has over 20 years experience in clinical and analytical biochemistry. Dr. Castillo is author to numerous manuscripts and presentations. Prior to PharmaIN, Dr. Castillo was Director of Biochemistry, ProteoTech, Inc. Dr. Castillo is a registered patent agent, and holder of over 40 patents. He received his BS, Biochemistry with honors from University of Saskatchewan, Canada, an MS in Clinical Chemistry from the University of Windsor, and his PhD, in Clinical Biochemistry from the University of Toronto, Canada.
Mark Edelsward, Director of Business Development
Mark has over 20 years of experience in technology sales leadership. Prior to PharmaIN, Mark was Vice President of WW Sales and Marketing at Data I/O Corp, Director of OEM Technology Sales at Microsoft and Vice President of International Sales at Listen Inc.
Sergey Rakhilin, PhD Director of Product Development
Dr. Rakhilin has extensive experience in drug discovery and developmental processes. Prior to PharmaIN, Dr. Rakhilin was Chief Scientific Officer at IBC Generium in Russia, a bio-therapeutic company, and Principal Scientist at Biogen Idec as well as Head of a drug discovery group at Novartis. Dr. Rakhilin received an MS and PhD in Biochemistry from Lomonosov Moscow State University with a post-doctoral fellowship at the University of Chicago and at Rockefeller University. He is the author of multiple publications and patents.
© PharmaIN 2016